MHAT 'Sv.Pantaleymon - Pleven' OOD

Pleven 5800

0 studies enrolling now · 3 studies all time

What they study most

Dyslipidemia, Parkinson's Disease, Type2 Diabetes

Studies at this site

• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• A Study to Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients — Status unconfirmed
• A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004 — Status unconfirmed